Weight loss drug reduced risk of COVID deaths in new study
A popular weight loss drug reduced the risk of COVID-19 deaths, according to a new study.
The research, published Friday in the Journal of the American College of Cardiology, found during a clinical trial of Wegovy that people taking the obesity drug during the COVID pandemic were less likely to die from the virus.
Semaglutide, the active medicine found in the drug, has become a popular option for people looking to lose weight. Wegovy has been widely used along with Ozempic, and both medicines are also used for the treatment of Type 2 diabetes.
People taking the drug still contracted the virus during the clinical trial, but their chances of dying dropped by 33 percent, the study found.
The pandemic began after the clinical trial was already underway and it provided researchers with the opportunity to “evaluate the effect of COVID-19 on patients who were at high risk of COVID-19-related complications and death given their underlying comorbidities and whether semaglutide modified that risk.”
The study, sponsored by Wegovy’s maker Novo Nordisk, had 17,694 participants who were diganosed with heart disease.
Of the participants, 4,258 became infected with COVID. About half of them were taking Wegovy and half were on a placebo drug.
The study said 184 people who were infected died. Of those who died, 106 were taking the placebo and 78 were taking Wegovy.
Dr. Jeremy Faust, an emergency room physician at Brigham and Women’s Hospital wrote an editorial accompanying the study.
“Pandemics reveal much about societies and expose their weaknesses. The lessons should motivate action,” he wrote. “That our population needs to be healthier is obvious."
"But repurposed research like the SELECT trial can yield less obvious insights, including the notion that semaglutide (and others like it) could have dramatically improved outcomes of a pandemic caused by a respiratory virus, of all things," Faust added.
He also told The New York Times in an interview that the data was “stunning.”
The research follows another recent study that found tirzepatide, the medicine found in weight loss drugs Zepbound and Mounjaro, reduced the severity of sleep apnea.
The study also comes as the World Health Organization and Food and Drug Administration have increased their warnings lately of counterfeit medication resembling the weight loss drugs.
Date: | |
Tag: | Covid |
-
Financial Times - Business
Roche data shows stomach-churning side effects of weight-loss drugs
High rates of vomiting among those who took strong doses in trials have unsettled investors4 hours ago -
ABC News - Top stories
Paramedic convicted in Elijah McClain's death freed after judge reduces sentence
Peter Cichuniec was found guilty of assault in the second degree for the unlawful administration of drugs and criminally negligent homicide in Elijah McClain's death.Yesterday -
Financial Times - World
Labour has no plans to lift ban on prison officers striking
Government ministers reject calls to repeal legislation despite union warning the decision would be seen as a betrayal15 hours ago -
The Guardian - World
‘Go woke, go broke’ not true for brands, says global advertising study
Research shows ad campaigns that are more inclusive have a positive impact on profits, sales and brand worth. The cringe factor can be high when an established brand suddenly aligns itself with ...7 hours ago -
The New York Times - World
How a Tourist Paradise Became a Drug-Trafficking Magnet
Costa Rica’s lush rainforests, which blanket a quarter of the country, are being infiltrated by cartels on a quest to find new trafficking routes to evade the authorities.5 hours ago -
BBC News - Top stories
Family 'devastated' by Great North Run death
Sam Wealleans' parents say they are "overwhelmed by thousands of kind messages" of support.4 hours ago -
ABC News - Top stories
A Minnesota man gets 33 years for fatally stabbing his wife during Bible study
He pleaded guilty in March to second-degree murder, apologized in court Friday.16 hours ago -
ESPN - Sports
Seminoles' skid continues with loss to Memphis
Koby Drake and the Memphis Tigers extended Florida State's early-season misery on Saturday afternoon, defeating the Seminoles 20-12, which gave coach Mike Norvell's team an 0-3 start to the season ...13 hours ago -
BBC News - Top stories
Man, 18, charged with triple murder over Luton tower block deaths
Nicholas Prosper, 18, is charged with the murders of a woman and two teenagers in a flat in Luton.16 hours ago
More from The Hill
-
The Hill - Politics
How a Trump-Musk government efficiency commission might affect NASA
Such a commission would be the perfect vehicle for looking at NASA, an agency with a storied history beset with a slew of problems.47 minutes ago - Donald Trump -
The Hill - Politics
Vance says ‘of course' Trump has a plan 'to fix American health care'
Sen. JD Vance (R-Ohio), the Republican nominee for vice president, said "of course" former President Trump has a plan to "fix American health care" in a Sunday interview and also outlined several ...57 minutes ago - Donald Trump -
The Hill - Politics
Why do most school buses not have seat belts?
School buses frequently lack a safety feature that, if you were caught not wearing one, would result in a ticket — but why?1 hour ago -
The Hill - Politics
Vance won’t say whether Trump would veto federal abortion ban: ‘I’ve learned my lesson’
Sen. JD Vance (R-Ohio), the GOP vice-presidential nominee, declined to say on Sunday whether former President Trump, if elected, would veto a federal abortion ban, saying, “I’ve learned my lesson” ...1 hour ago - Donald Trump -
The Hill - Politics
Punish the administrators, not the researchers, for campus antisemitism
Congressional appropriations committees can use federal funding cuts to punish campus antisemitism without damaging the essential need for support of basic research.1 hour ago